A 6-month-old infant from rural India presents with fever, cough, and respiratory distress. The child has received all vaccines as per the National Immunisation Schedule up to 6 months of age. On examination, there is hepatosplenomegaly and generalised lymphadenopathy. The clinician suspects tuberculosis. Which investigation is most appropriate to confirm the diagnosis in this infant?

Explanation

## Diagnosis of Tuberculosis in Vaccinated Infants ### Clinical Context The infant has received BCG vaccine (at birth as per NIS), which provides partial protection against severe TB but does NOT prevent infection or latent TB. The presence of hepatosplenomegaly, lymphadenopathy, and respiratory symptoms in a 6-month-old suggests disseminated or pulmonary TB. ### Why GeneXpert MTB/RIF on Gastric Aspirate is the Investigation of Choice **Key Point:** In young children (<5 years), sputum production is minimal or absent. Gastric aspirate is the gold standard specimen for TB diagnosis in this age group because: 1. Children swallow sputum and gastric secretions contain mycobacteria 2. GeneXpert MTB/RIF is WHO-recommended as the first-line molecular test 3. It detects TB DNA and simultaneously tests for rifampicin resistance 4. Sensitivity is 60–80% in culture-confirmed TB in children **High-Yield:** GeneXpert MTB/RIF is rapid (2 hours), sensitive, specific, and detects drug resistance — making it superior to culture for clinical decision-making in resource-limited settings. ### Diagnostic Algorithm for TB in Infants ```mermaid flowchart TD A[Suspected TB in infant <5 years]:::outcome --> B{Can child produce sputum?}:::decision B -->|No or minimal| C[Collect gastric aspirate]:::action B -->|Yes| D[Collect sputum]:::action C --> E[GeneXpert MTB/RIF]:::action D --> E E --> F{MTB detected?}:::decision F -->|Yes| G[Confirm TB + assess RIF resistance]:::outcome F -->|No| H[Chest X-ray + clinical score]:::action H --> I[Classify as TB or rule out]:::outcome ``` ### Why Mantoux Test is Inadequate Here **Warning:** Mantoux test (TST) measures delayed-type hypersensitivity to TB antigen. It: - Does NOT differentiate active TB from latent TB or BCG vaccination - Is unreliable in infants <6 months (immune response not yet mature) - Cannot be used alone to diagnose active disease - Is positive in BCG-vaccinated children, causing false positives Mantoux is useful for contact tracing or screening, not diagnosis of active TB. ### Why Sputum Smear Microscopy is Inappropriate **Clinical Pearl:** Smear microscopy requires: - Productive cough with adequate sputum volume (infants cannot expectorate) - High bacillary load (children with TB typically have paucibacillary disease) - Sensitivity in children is only 10–15%, making it unreliable It is NOT the investigation of choice in this age group. ### Why Chest X-ray Alone is Insufficient Chest X-ray findings (hilar lymphadenopathy, consolidation, miliary pattern) are suggestive but NOT diagnostic. It must be combined with: - Microbiological confirmation (GeneXpert MTB/RIF) - Clinical scoring (Revised National TB Control Programme criteria) X-ray guides clinical suspicion but cannot confirm TB microbiologically. ### National Immunisation Schedule Context **Key Point:** BCG vaccine (given at birth) protects against severe TB (meningitis, disseminated disease) in ~80% of infants but does NOT prevent: - Infection after exposure - Progression to active TB disease - Latent TB reactivation This child's presentation suggests breakthrough TB despite vaccination, requiring microbiological confirmation.